Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

(2018) David E Kandzari et al.   LANCET

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

(2018) Michel Azizi et al.   LANCET

Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality

(2018) José R. Banegas et al.   NEW ENGLAND JOURNAL OF MEDICINE

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Effect of renal denervation on kidney function in patients with chronic kidney disease

(2017) Dagmara Hering et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

(2017) Raymond R Townsend et al.   LANCET

Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) TrialClinical Perspective

(2016) Michel Azizi et al.   CIRCULATION

Rate of Change in Renal Function and Mortality in Elderly Treated Hypertensive Patients

(2015) E. K. Chowdhury et al.   Clinical Journal of the American Society of Nephrology

First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension

(2015) M. Bohm et al.   HYPERTENSION

Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension

(2015) Christian Ott et al.   JOURNAL OF HYPERTENSION

Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial

(2015) Michel Azizi et al.   LANCET

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

(2015) Bryan Williams et al.   LANCET

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Renal Denervation for the Treatment of Cardiovascular High Risk-Hypertension or Beyond?

(2014) Michael Böhm et al.   CIRCULATION RESEARCH

Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial

(2014) Murray D. Esler et al.   EUROPEAN HEART JOURNAL

Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

(2014) D. E. Kandzari et al.   EUROPEAN HEART JOURNAL

Renal artery stenosis following renal denervation

(2014) Alexandre Persu et al.   JOURNAL OF HYPERTENSION

Prevalence of and Risk Factors of Renal Artery Stenosis in Patients With Resistant Hypertension

(2013) Mina M. Benjamin et al.   AMERICAN JOURNAL OF CARDIOLOGY

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Vascular and Renal Hemodynamic Changes after Renal Denervation

(2013) C. Ott et al.   Clinical Journal of the American Society of Nephrology

European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring

(2013) Eoin O’Brien et al.   JOURNAL OF HYPERTENSION

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

(2013) Henry Krum et al.   LANCET

Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry

(2013) Michael Böhm et al.   EuroIntervention

Renal Sympathetic Denervation Suppresses De Novo Podocyte Injury and Albuminuria in Rats With Aortic Regurgitation

(2012) Kazi Rafiq et al.   CIRCULATION

Predictors of Estimated GFR Decline in Patients with Type 2 Diabetes and Preserved Kidney Function

(2012) G. Zoppini et al.   Clinical Journal of the American Society of Nephrology

Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension

(2012) Felix Mahfoud et al.   HYPERTENSION

Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension

(2012) Dagmara Hering et al.   HYPERTENSION

Relationship between Blood Pressure and Incident Chronic Kidney Disease in Hypertensive Patients

(2011) R. Hanratty et al.   Clinical Journal of the American Society of Nephrology

Renal function and target organ damage in hypertension

(2011) L. M. Ruilope et al.   EUROPEAN HEART JOURNAL

Early Sympathetic Activation in the Initial Clinical Stages of Chronic Renal Failure

(2011) Guido Grassi et al.   HYPERTENSION

Biological, clinical, and ethical advances of placebo effects

(2010) Damien G Finniss et al.   LANCET

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

(2010)   LANCET

Determinants of Decline in Glomerular Filtration Rate in Nonproteinuric Subjects with or without Diabetes and Hypertension

(2009) H. Yokoyama et al.   Clinical Journal of the American Society of Nephrology

Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension

(2009) Markus P. Schlaich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sympathetic Activation in Chronic Renal Failure

(2008) M. P. Schlaich et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY